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Children whose twins have had leukaemia have a higher risk of contracting acute lymphoblastic leukaemia (ALL), confirming a
prenatal origin of the disease. This association was not true when considering other types of affected first-degree relatives. Children
whose fathers were diagnosed with testicular cancer have a higher risk of ALL.
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Although acute lymphoblastic leukaemia (ALL) is the most
common neoplasia among children worldwide (Parkin et al,
1999), many aspects of its aetiology remain unclear. Ionising
radiation, Down’s syndrome and ataxia-telangietasia are estab-
lished risk factor for childhood ALL (Greaves, 1997; Little, 1999).
Possible associations between childhood ALL risk and infection,
and prenatal factors have been suggested (MacMahon, 1992;
Kinlen et al, 1990; Kinlen, 1995; Wiemels et al, 1999; Greaves et al,
2003; Stiller, 2004; Gilham et al, 2005). Results from epidemio-
logical studies investigating the familial risk of childhood ALL
are difficult to interpret, generally because of small sample size.
Published studies have considered a wide range of cancers
diagnosed in relatives, ranging from family histories of leukaemia
(Buckley et al, 1996; Hemminki et al, 2001a); or more broadly,
family histories of haematologic neoplasms (Perrillat et al, 2001;
Infante-Rivard and Guiguet, 2004) and solid tumours (Perrillat
et al, 2001). Results from these studies are inconclusive. Children
with parents diagnosed with leukaemia were reported to have a
similar risk of ALL as the general population (Hemminki and
Mutanen, 2001b). A higher risk of leukaemia was observed among
children with affected siblings (Hemminki et al, 2001a).
This population-based cohort study aims to investigate the risk
of childhood ALL associated with a family history of leukaemia
and other neoplasms in parents and/or siblings.
MATERIAL AND METHODS
Study population
Data from the Swedish Family-Cancer Database were used. This
Database was described in detail previously (Hemminki et al,
2001c). Briefly, the Swedish Family-Cancer Database was created
linking four different national sources of information: the multi-
generation register, censuses, cancer registries and national deaths
notifications. The multigeneration register includes people born in
Sweden after 1931, and parents born in 1864 and after. Information
from censuses of years 1960, 1970, 1980 and 1990 was also used.
Cancers were identified trough the Swedish Cancer Registry that
covers cancers diagnosed between 1958 and 2002. Information
obtained through these sources was linked together using the
national 10-digit personal number; this information was available
for all the participants. Familial relationships were determined
using the multigeneration register. 406091 participants whose
either parent’s personal number was missing were excluded as
sibships could not be determined. Only histories of cancers among
mothers, fathers and siblings were considered.
Participants born between 1932 and 2002 were included, and
cases of childhood ALL, (International Classification of Diseases,
7th revision, coding 204.0), diagnosed between 1961 and 2002, and
aged less than 20 years old were considered.
Statistical methods
Standardised incidence ratios (SIRs) for childhood ALL were
calculated dividing the observed number of ALL by the expected
number of cases. The SIRs were stratified by follow-up period
(1961–1969, 1970–1979, 1980–1989, 1990–2002), and age using
5 years categories. 95% Confidence intervals (CI) were obtained
assuming a Poisson distribution (Altman et al, 2000).
SIRs of childhood ALL were estimated comparing people with
first-degree relatives diagnosed with leukaemia to the general
population. This was also carried out considering 34 other type of
cancers among relatives. Only results for cancer sites with five
or more cases in children with affected relatives are reported here
(18 out of 34).
RESULTS
In the total population of 6994345 individuals, 1925 cases
of childhood ALL were ascertained. Only 19 of those had
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ya first-degree relative diagnosed with leukaemia, with a SIR for
childhood ALL of 2.21 (95% CI: 1.33–3.45) (Table 1). However,
this increase in risk remained statistically significant only when the
affected relative was a twin. The SIR for childhood ALL in
participants with twins diagnosed with any type of leukaemia was
equal to 208.28 (54.05–641.09), compared to 1.27 (0.55–2.50) and
2.22 (0.51–7.32) when the affected relatives were parents and
siblings (excluding twins), respectively. All affected twins were
females. The SIR for childhood ALL was 2.18 (0.94–4.30) when
first-degree relatives (excluding twins) were diagnosed with acute
lymphoblastic leukaemia; when including twins, this SIR was equal
to 3.80 (2.08–6.38). The SIR for childhood ALL when relatives
were diagnosed with myeloid leukaemia was 1.25 (0.34–3.20)
(Table 1).
When investigating the risk of childhood ALL associated with
histories of other types of cancer among first-degree relatives, only
children with parents diagnosed with testicular cancer showed
an increase in risk. The SIR of childhood ALL for such offspring
was 3.12 (95% CI: 1.50–5.75) (Table 2). Only the SIR for childhood
ALL when parents were diagnosed with malignant testicular
teratoma was statistically significant, 4.10 (1.29–9.64) compared
to 2.26 (0.59–5.85) for seminoma. The five paternal teratomas
were diagnosed between years 1982 and 1996 at ages 26–38 years:
three of the fathers were diagnosed before conception of the child
who was to be diagnosed with ALL.
DISCUSSION
Children with twins diagnosed with leukaemia had a much higher
risk of contracting acute lymphoblastic leukaemia than the general
population. This increase in risk was not observed with other
type of affected first-degree relatives, such as parents or siblings
(excluding twins).
In this large study, the data were obtained through Swedish
national registries. These registries were reported to be close to
100% complete (Centre for Epidemiology, 2000), including most of
the Swedish population in the periods covered by these registries.
The results reported in this article are, therefore, generalisable to
the whole population. Familial relationships were determined
using information from the multigeneration registry, which is
more reliable than using self-reported family histories.
Previous publications using information from the same
Database reported no increase in childhood ALL when parents
were diagnosed with leukaemia (Hemminki and Mutanen, 2001b).
A higher risk of leukaemia in people with siblings diagnosed with
the disease was reported, but this investigation did not examine
the risk associated with having affected twins (Hemminki et al,
Table 1 Standardised incidence ratios (SIRs) for childhood acute
lymphoblastic leukaemia associated with a family history of leukaemia
Family history of Obs.
a SIRs
b (95% CI)
Any type of leukaemia (ICD
c: 204–209), in:
Any first-degree relatives 19 2.21 (1.33–3.45)
Parents only 8 1.27 (0.55–2.50)
Siblings only 11 4.82 (1.70–12.20)
Siblings excluding twins 5 2.22 (0.51–7.32)
Twins 6 208.28 (54.05–641.09)
Acute lymphoblastic leukaemia (ICD 204.0), in
Any first degree relatives 14 3.80 (2.08–6.38)
Any first-degree relatives excluding twins 8 2.18 (0.94–4.30)
Myeloid leukaemia (ICD 205), in
Any first degree relatives 4 1.25 (0.34–3.20)
Any first-degree relatives excluding twins 4 1.25 (0.34–3.20)
aObserved number of cases.
bSIRs stratified by age and follow-up period.
cInternational Classification of Disease.
Table 2 Standardised incidence ratios (SIRs
a) for childhood acute lymphoblastic leukaemia in children with relatives diagnosed with different type of
cancers
Relatives affected
Parents only Siblings only
Cancer in relatives Obs. SIRs (95% CI) Obs. SIRs CI (95% CI)
Stomach 7 1.32 (0.53–2.73)
Colon 11 0.89 (0.44–1.60)
Rectum 5 0.67 (0.22–1.55)
Pancreas 6 1.42 (0.52–3.08)
Lung 18 1.26 (0.74–1.98)
Breast 40 1.00 (0.71–1.36) 3 1.49 (0.22–6.17)
Cervix 7 1.02 (0.41–2.10)
Endometrium 7 1.43 (0.57–2.94) 1 6.51 (0.12–51.34)
Ovary 9 1.51 (0.69–2.86)
Prostate 24 1.09 (0.70–1.62)
Testicular 10 3.12 (1.50–5.75) 1 0.87 (0.02–6.85)
Seminoma 4 2.26 (0.59–5.85)
Teratoma 5 4.10 (1.29–9.64)
Urinary bladder 9 1.00 (0.46–1.91)
Melanoma 11 0.77 (0.39–1.39) 1 0.61 (0.01–4.80)
Nervous system 11 0.95 (0.47–1.69) 3 0.92 (0.13–3.78)
Thyroid gland 4 1.06 (0.29–2.72) 1 1.95 (0.03–15.39)
Connective tissue 5 2.38 (0.77–5.56) 1 2.08 (0.04–16.37)
Non-Hodgkin’s disease 7 0.88 (0.35–1.82)
Hodgkin’s disease 4 1.82 (0.50–4.65) 2 2.31 (0.20–11.83)
aSIRs stratified by age and follow-up period.
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publications using the same data. Indeed, four new more years of
follow-up were added. Furthermore, a stricter criterion of selection
for parents was carried out. In the present report, people with
missing information for any parents were excluded, while
previously offspring with information on at least one of the
parents were considered. The present publication investigates
further the association between having a father diagnosed with
testicular cancer and the risk of childhood ALL by considering
different histological types of testicular cancers.
This study adds substantially to previous studies, as it
investigates the familial cancer risk of childhood ALL considering
different types of leukaemia in affected first-degree relatives.
Indeed, epidemiological studies have mainly considered family
histories of other malignancies than ALL in first-degree relatives,
such as solid tumours (Perrillat et al, 2001) and haematologic
neoplasms (Perrillat et al, 2001; Infante-Rivard and Guiguet, 2004).
In those studies, no statistically significant increase in risk of
childhood ALL was found. Winther et al (2001) reported no
increase in risk of leukaemia in people whose siblings were
diagnosed with childhood leukaemia.
In this article, a very high risk of childhood ALL was found in
people with twins diagnosed with leukaemia. All the twin pairs for
whom at least one of them was affected were females, suggesting
that they were monozygotic twins. Commonly, increases in cancer
risk seen in people with close relatives diagnosed with cancer are
suggested to be associated with shared genes and/or post-natal
environment. However, it has been mentioned that due to the
young age at onset of childhood ALL and the latency expected for
cancer evolution, it is possible that the disease originates before
birth (Greaves, 1999). It has been hypothesised that the sharing of
placenta of monozygotic twins might contribute toward concor-
dance of leukaemia (Greaves et al, 2003).
In the present study, when considering 18 different cancer sites
diagnosed in first-degree relatives, an increase of childhood ALL
was found only in participants with parents diagnosed with
testicular cancer. Due to the large number of cancers considered, it
is possible that the higher risk observed in these children is due
to chance. An unproven explanation could be that the treatment
of fathers for testicular cancer with cisplatin caused permanent
damage to sperm which could contribute to the higher risk of ALL
observed in offspring (Greene, 1992). When considering seminoma
and teratoma histological types separately, an increase in risk
of childhood ALL was observed among children whose fathers
were diagnosed with malignant teratoma. This was not true for
malignant seminoma. Among the five malignant teratomas
diagnosed in fathers of children with ALL, three were diagnosed
before conception of the child. Those testicular cancers were
diagnosed in 1991 and 1996. The use of cisplatin to treat testicular
cancer has started in the 1970s (IARC Monographs, 1981), and is
still in use, hence the three malignant teratomas occurring before
the birth of the child to be diagnosed with ALL were most probably
all treated with cisplatin.
More studies are needed to investigate whether the increased
risk of ALL observed in children with twins diagnosed with
leukaemia is associated with common familial factors such as
shared genes and/or postnatal environment, or if it is more
explained by prenatal factors.
This population-based cohort study indicates that children with
first-degree relatives diagnosed with leukaemia have a higher risk
of contracting ALL. However, this increase in risk seems to exist
only when the affected relative is a twin, confirming a prenatal
origin of childhood ALL.
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